CitivasTM
Citicoline
Cerebral Peripheral Vasotherpeutics (CNS Preparations)
Indication:
a) Cerebrovascular disease e.g. from ischemia due to stroke, where Citicoline accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months.
b) Cerebral insufficiency (e.g. dizziness, memory loss, poor concentration & disorientation) due to head trauma or brain injury.
c) Cognitive dysfunction due to degenerative disease (Alzheimer’s disease)
d) Parkinson’s disease- Citicoline has been shown to be effective as co-therapy for Parkinson’s disease.
Dosage & Administration:
a) Immediate treatment of stroke due to a clot (ischemic stroke): 500-2000 mg of Citicoline per day, start within 24 hours of stroke.
b) For decline in thinking skills due to stroke: 1000-2000 mg of Citicoline per day.
c) Chronic cerebrovascular disease: 1000 mg daily in divided dose with or between meals for ongoing disease of the blood vessels that serve the brain.
Preparation:
CitivasTM Caplet: Each box contains 1×10 caplets in Alu-Alu blister pack.
